Lysophosphatidylcholine up-regulates human endothelial nitric oxide synthase gene transactivity by c-Jun N-terminal kinase signalling pathway

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 6, 2009, Pages 1136-1148

  Xing, Feiyue ^a,b   Liu, Jing ^a   Mo, Yongyan ^b   Liu, Zhifeng ^b   Qin, Qinghe ^b   Wang, Jingzhen ^b   Fan, Zhenhua ^a   Long, Yutian ^a   Liu, Na ^a   Zhao, Kesen ^b   Jiang, Yong ^b  

^a JINAN UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Endothelial nitric oxide synthase; Lysophosphatidylcholine; Mitogen activated protein kinase; Regulation; Transactivity

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME INHIBITOR; FLAVONOID; GREEN FLUORESCENT PROTEIN; IMIDAZOLE DERIVATIVE; LYSOPHOSPHATIDYLCHOLINE; MITOGEN ACTIVATED PROTEIN KINASE; PYRIDINE DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1; 2-(2-AMINO-3-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE; DNA PROBE; PROTEIN BINDING;

ARTICLE; CELL LINE; DNA PROBE; DRUG ANTAGONISM; DRUG EFFECT; FLUORESCENCE MICROSCOPY; GEL MOBILITY SHIFT ASSAY; GENETICS; HUMAN; METABOLISM; PHOSPHORYLATION; PROMOTER REGION; PROTEIN BINDING; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UPREGULATION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS;

BLOTTING, WESTERN; CELL LINE; DNA PROBES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME INHIBITORS; FLAVONOIDS; GREEN FLUORESCENT PROTEINS; HUMANS; IMIDAZOLES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LYSOPHOSPHATIDYLCHOLINES; MICROSCOPY, FLUORESCENCE; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PYRIDINES; SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 67649878811     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00394.x     Document Type: Article

References (44)

1. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J. 2001 357 : 593 615. (Pubitemid 32735142)
2. Atochin DN, Wang A, Liu VW, Critchlow JD, Dantas AP, Looft-Wilson R, Murata T, Salomone S, Shin HK, Ayata C, Moskowitz MA, Michel T, Sessa WC, Huang PL. The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. J Clin Invest. 2007 117 : 1961 7.
3. Bao M, Lou Y. Flavonoids from seabuck-thorn protect endothelial cells (EA.hy926) from oxidized low-density lipoprotein induced injuries via regulation of LOX-1 and eNOS expression. J Cardiovasc Pharmacol. 2006 48 : 834 41.
4. Braam B, Verhaar MC. Understanding eNOS for pharmacological modulation of endothelial function: a translational view. Curr Pharm Des. 2007 13 : 1727 40.
5. Millanvoye-Van Brussel E, Topal G, Brunet A, Do Pham T, Deckert V, Rendu F, David-Dufilho M. Lysophosphatidylcholine and 7-oxocholesterol modulate Ca2+ signals and inhibit the phosphorylation of endothelial NO synthase and cytosolic phospholipase A2. Biochem J. 2004 380 : 533 9.
6. Cieslik K, Abrams CS, Wu KK. Up-regulation of endothelial nitric-oxide synthase promoter by the phosphatidylinositol 3-kinase gamma/Janus kinase 2/MEK-1-dependent pathway. J Biol Chem. 2001 12 : 1211 9.
7. Cieslik K, Lee CM, Tang JL Wu KK. Transcriptional regulation of endothelial nitric-oxide synthase by an interaction between casein kinase 2 and protein phos-phatase 2A. J Biol Chem. 1999 274 : 34669 75.
8. Colombo MG, Paradossi U, Andreassi MG, Botto N, Manfredi S, Masetti S, Biagini A, Clerico A. Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. Clin Chem. 2003 49 : 389 95.
9. Du Toit EF, Genade S, Carlini S, Moolman JA, Brunner F, Lochner A. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model. Eur J Pharmacol. 2007 556 : 115 20.
10. Faustino RS, Stronger LNW, Melanie N. RanGAP-mediated nuclear protein import in vascular smooth muscle cells is augmented by lysophosphatidylcholine. Mol Pharmacol. 2007 71 : 438 45.
11. Fleming I, Busse R. Signal transduction of eNOS activation. Cardiovasc Res. 1999 43 : 532 41.
12. Gan L, Selin-Sjogren L, Doroudi R, Jern S. Temporal regulation of endothelial ET-1 and eNOS expression in intact human conduit vessels exposed to different intraluminal pressure levels at physiological shear stress. Cardiovas Res. 2000 48 : 168 77.
13. Garcia-Parajo MF, Koopman M, van Dijk EM, Subramaniam V, van Hulst NF. The nature of fluorescence emission in the red fluorescent protein DsRed, revealed by single-molecule detection. Proc Natl Acad Sci USA. 2001 98 : 14392 7.
14. Gill RM, Braz JC, Jin N, Etgen GJ, Shen W. Restoration of impaired endothelium-dependent coronary vasodilation in failing heart: role of eNOS phosphorylation and CGMP/cGK-I signaling. Am J Physiol Heart Circ Physiol. 2007 292 : H2782 90.
15. Gouni-Berthold I, Sachinidis A. Possible non-classic intracellular and molecular mechanisms of LDL cholesterol action contributing to the development and progression of atherosclerosis. Curr Vasc Pharmacol. 2004 2 : 363 70.
16. Gousset-Dupont A, Robert V, Grynberg A. The effect of n-3 PUFA on eNOS activity and expression in Eahy 926 cells. Prostaglandins Leukot Essent Fatty Acids. 2007 76 : 131 9.
17. Hoffmann A, Gloe T, Pohl U. Hypoxia-induced upregulation of eNOS gene expression is redox-sensitive: a comparison between hypoxia and inhibitors of cell metabolism. J Cell Physiol. 2001 188 : 33 44. (Pubitemid 32476494)
18. Jin HG, Yamashita H, Nagano Y, Fukuba H, Hiji M, Ohtsuki T, Takahashi T, Kohriyama T, Kaibuchi K, Matsumoto M. Hypoxia-induced upregulation of endothe-lial small G protein RhoA and Rho-kinase/ROCK2 inhibits eNOS expression. Neurosci Lett. 2006 408 : 62 7.
19. Jones SP, Greer JJM, Haperen RV, Duncker DJ, Crom RD, Lefer DJ. Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice. Proc Natl Acad Sci USA. 2003 100 : 4891 6.
20. Karantzoulis-Fegaras F, Antoniou H, Lai SL, Kulkarni G, D'Abreo C, Wong GK, Miller TL, Chan Y, Atkins J, Wang Y, Marsden PA. Characterization of the human endothelial nitric-oxide synthase promoter. J Biol Chem. 1999 274 : 3076 93.
21. Kudo Y, Ootani T, Kumagai T, Fukuchi Y, Ebin K, Yokota K. A novel oxidized low-density lipoprotein-binding protein, Asphemolysin, recognizes lysophosphatidyl-choline. Biol Pharm Bull. 2002 25 : 787 90.
22. Leonard AM, Chafe LL, Montani JP, Van Vliet BN. Increased salt-sensitivity in endothelial nitric oxide synthase-knockout mice. Am J Hypertens. 2006 19 : 1264 9.
23. Li H, Burkhardt C, Heinrich UR, Brausch I, Xia N, Forstermann U. Histamine upregulates gene expression of endothelial nitric oxide synthase in human vascular endothelial cells. Circulation. 2003 107 : 2348 54.
24. Li H, Junk P, Huwiler A, Burkhardt C, Wallerath T, Pfeilschifter J, Förstermann U. Dual effect of ceramide on human endothelial cells induction of oxidative stress and transcriptional upregulation of endothelial nitric oxide synthase. Circulation. 2002 106 : 2250 6.
25. Li Z, Song T, Liu GZ, Liu LY. Inhibitory effects of cariporide on LPC-induced expression of ICAM-1 and adhesion of monocytes to smooth muscle cells in vitro. Acta Pharmacol. 2006 27 : 1326 32.
26. Liu L, Liu H, Visner G, Fletcher BS. Sleeping Beauty-mediated eNOS gene therapy attenuates monocrotaline-induced pulmonary hypertension in rats. FASEB J. 2006 20 : 2594 6.
27. Lund CO, Mortensen A, Nilas L, Breinholt VM, Larsen JJ, Ottensen B. Estrogen and phytoestrogens: effect on eNOS expression and in vitrovasodilation in cerebral arteries in ovariectomized Watanabe heritable hyperlipidemic rabbits. Eur J Obstet Gynecol Reprod Biol. 2007 130 : 84 92. (Pubitemid 44918199)
28. Mathew R, Huang J, Gewitz MH. Pulmonary artery hypertension: caveolin-1 and eNOS interrelationship: a new perspective. Cardiol Rev. 2007 15 : 143 9.
29. Miller WH, Brosnan MJ, Graham D, Nicol CG, Morecroft I, Channon KM, Daniloy SM, Reynolds PN, Baker AH, Dominiczak AF. Targeting endothelial cells with adenovirus expressing nitric oxide synthase prevents elevation of blood pressure in stroke-prone spontaneously hypertensive rats. Mol Ther. 2005 12 : 321 7.
30. Murugesan G, Sandhya Rani MR, Gerber CE, Mukhopadhyay C, Ransohoff RM, Chisolm GM, Kottke-Marchant K. Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines. J Mol Cell Cardiol. 2003 35 : 1375 84.
31. Nakano T, Raines EW, Abraham JA, Klagsbrun M, Ross R. Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factorlike growth factor mRNA in human monocytes. Proc Natl Acad Sci USA. 1994 91 : 1069 73.
32. Ozaki H, Ishii K, Arai H, Kume N, Kita T. Lysophosphatidylcholine activates mito-gen-activated protein kinases by a tyrosine kinase-dependent pathway in bovine aortic endothelial cells. Atherosclerosis. 1999 143 : 261 6.
33. Rosenblat M, Ore R, Aviram M. Lysophosphatidylcholine (LPC) attenuates macrophage-mediated oxidation of LDL. Biochem Biophys Res Commun. 2006 344 : 1271 7.
34. Safaya R, Chai H, Kougias P, Lin P, Lumsden A, Yao Q, Chen C. Effect of lysophosphatidylcholine on vasomotor functions of porcine coronary arteries. J Surg Res. 2005 126 : 182 8.
35. Saura M, Zaragoza C, Cao W, Bao C, Rodriguez-Puyol M, Rodriguez-Puyol D, Lowenstein CJ. Smad2 mediates transforming growth factor-beta induction of endothelial nitric oxide synthase expression. Circ Res. 2002 91 : 806 13.
36. Shi Y, Baker JE, Zhang C, Tweddell JS, Su J, Pritchard KA. Chronic hypoxia increases endothelial nitric oxide synthase generation of nitric oxide by increasing heat shock protein 90 association and serine phosphorylation. Circ Res. 2002 91 : 300 6.
37. Takemoto M, Sun J, Hiroki J, Shimokawa H, Liao JK. Rho-kinase mediates hpoxia-induced downregulation of endothelial nitric oxide synthase. Circulation. 2002 106 : 57 62. (Pubitemid 34747442)
38. Thors B, Halldorsson H, Clarke GD, Thorgeirsson G. Inhibition of Akt phosphorylation by thrombin, histamine and lysophosphatidylcholine in endothelial cells Differential role of protein kinase C. Atherosclerosis. 2003 168 : 245 53.
39. Wallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K, Forstermann U. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation. 2002 106 : 1652 8.
40. Wedgwood S, Mitchell CJ, Fineman JR, Black SM. Developmental differences in the shear stress-induced expression of endothelial NO synthase: changing role of AP-1. Am J Physiol Lung Cell Mol Physiol. 2003 284 : L650 2.
41. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA. 1994 91 : 5212 6.
42. Wu KK. Regulation of endothelial nitric oxide synthase activity and gene expression. Ann NY Acad Sci. 2002 962 : 122 30.
43. Xing FY, Jiang Y, Liu J, Zhao KS, Mo YY, Qin QH, Wang JZ, Ouyang JM, Zeng YY. Role of AP1 element in the activation of human eNOS promoter by lysophosphatidylcholine. J Cell Biochem. 2006 98 : 872 84.
44. Yamakawa T, Tanaka S, Yamakawa Y, Kamei J, Numaguchi K, Motley ED, Inagami T, Eguchi S. Lysophos-phatidylcholine activates extracellular signal-regulated kinases 1/2 through reactive oxygen species in rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2002 22 : 752 8.